Aptose Biosciences: Hits one-month low after discounted share offering
** Biotechnology company APTO.O falls 15.2% to $1.91,
lowest in a month
** Co announced stock offering of 10 mln shares on Thursday,
priced at $1.85/shr urn:newsml:reuters.com:*:nL8N2363ZR
** Offering at a discount of 17.8% to its closing price on
Wednesday
** RBC Capital Markets and Canaccord Genuity are acting as
joint book-running managers for the offering
** Up to Wednesday's close, shares had fallen 36.4% over the
last one year
(Reporting By Aparajita Saxena in Bengaluru)
((Aparajita.Saxena@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806 749 8901; Reuters Messaging:
aparajita.saxena.thomsonreuters.com@reuters.net))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting